ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

Howard Temin, 59, NCAB Member, Nobel Laureate, Dead

February 18, 1994

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

NCI To Fund 23 CHOPs, More Singles Than Multiples; ACCC Expresses Concern

August 8, 1980

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms

May 26, 1995

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993